The Hindu Business Line : Dr Reddy's anti-acne gel

Pharma major Dr Reddy's Laboratories Ltd has launched Nexret for the treatment of acne in India. The launch of the drug, in gel formulation, marked the entry of the Hyderabad-based company into the topical anti-acne segment, a commonly diagnosed condition by dermatologists. "Nexret (Tretinoin 0.04 per cent and 0.1 per cent as microspheres) is a next generation anti-acne formulation made from a proprietary non-porous microsphere technology. This technology minimises irritation associated with drugs like Tretinoin and provides controlled delivery of drug to the skin," the company said in a release. The anti-acne market in India is about Rs 130 crore and is growing at the rate of about 14 per cent a year. - Our Bureau

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy's anti-acne gel

ACC case: High Court sets aside sales tax assessment orders

Aditya Birla Nuvo dips deeper into red

Lower realisations hit Sterlite bottomline

Eveready Industries back in black

Asset impairment dents Aban’s profitability

Oil refiners walk the tightrope for 2008-09

India projects high priority: ArcelorMittal

Biocon eyes biogenerics ride to US

Havells targets 50% growth in Kerala

Anchor to market lighting systems for industrial use next year